Covered recipient · General Payments record
LALITA GUPTA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,806.59
- Reported across 236 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $505.30 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $155.82 | 14 |
| GlaxoSmithKline, LLC. | $68.66 | 4 |
| Abbott Laboratories | $53.70 | 3 |
| Amgen Inc. | $51.98 | 3 |
| ABBVIE INC. | $40.48 | 3 |
| Astellas Pharma US Inc | $30.45 | 2 |
| SANOFI-AVENTIS U.S. LLC | $25.34 | 1 |
| Corcept Therapeutics | $23.34 | 1 |
| PFIZER INC. | $21.84 | 1 |
| DEXCOM, INC. | $17.63 | 1 |
| Lilly USA, LLC | $16.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.97 | 02/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125070505 | CMS |
| Abbott Laboratories | $20.34 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125070507 | CMS |
| Abbott Laboratories | $14.39 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125070509 | CMS |
| ABBVIE INC. | $13.98 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103852520 | CMS |
| ABBVIE INC. | $13.14 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103852522 | CMS |
| ABBVIE INC. | $13.36 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103852524 | CMS |
| Amgen Inc. | $16.70 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111591350 | CMS |
| Amgen Inc. | $17.54 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111591352 | CMS |
| Amgen Inc. | $17.74 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111591354 | CMS |
| Astellas Pharma US Inc | $15.60 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139299654 | CMS |
| Astellas Pharma US Inc | $14.85 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139352145 | CMS |
| Corcept Therapeutics | $23.34 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117749045 | CMS |
| Dexcom, Inc. | $17.63 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153315364 | CMS |
| GlaxoSmithKline, LLC. | $13.84 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116392712 | CMS |
| GlaxoSmithKline, LLC. | $14.30 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116360418 | CMS |
| GlaxoSmithKline, LLC. | $16.58 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116364231 | CMS |
| GlaxoSmithKline, LLC. | $23.94 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116248773 | CMS |
| Lilly USA, LLC | $16.06 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135123059 | CMS |
| Novo Nordisk Inc | $11.31 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597948 | CMS |
| Novo Nordisk Inc | $12.47 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096946358 | CMS |
| Novo Nordisk Inc | $15.51 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096685744 | CMS |
| Novo Nordisk Inc | $15.55 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096942063 | CMS |
| Novo Nordisk Inc | $14.08 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097465637 | CMS |
| Novo Nordisk Inc | $0.65 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096588379 | CMS |
| Novo Nordisk Inc | $10.55 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096603731 | CMS |
| Novo Nordisk Inc | $16.32 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096987465 | CMS |
| Novo Nordisk Inc | $0.55 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096802950 | CMS |
| Novo Nordisk Inc | $5.26 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097197900 | CMS |
| Novo Nordisk Inc | $11.34 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097434245 | CMS |
| Novo Nordisk Inc | $16.72 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096990011 | CMS |
| Novo Nordisk Inc | $7.06 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096609930 | CMS |
| Novo Nordisk Inc | $18.45 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097488293 | CMS |
| PFIZER INC. | $21.84 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132125251 | CMS |
| SANOFI-AVENTIS U.S. LLC | $25.34 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990643 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.